Reply: the BIM deletion polymorphism cannot account for intrinsic TKI resistance of Chinese individuals with chronic myeloid leukemia.
Ong, S Tiong
Reply: the BIM deletion polymorphism cannot account for intrinsic TKI resistance of Chinese individuals with chronic myeloid leukemia. [electronic resource] - Nature medicine Oct 2014 - 1090-1 p. digital
Publication Type: Letter; Comment
1546-170X
10.1038/nm.3652 doi
Apoptosis--drug effects
Apoptosis Regulatory Proteins--genetics
Carcinoma, Non-Small-Cell Lung--genetics
Drug Resistance, Neoplasm--drug effects
Female
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--genetics
Lung Neoplasms--genetics
Male
Membrane Proteins--genetics
Polymorphism, Genetic--genetics
Protein Kinase Inhibitors--pharmacology
Proto-Oncogene Proteins--genetics
Sequence Deletion--genetics
Reply: the BIM deletion polymorphism cannot account for intrinsic TKI resistance of Chinese individuals with chronic myeloid leukemia. [electronic resource] - Nature medicine Oct 2014 - 1090-1 p. digital
Publication Type: Letter; Comment
1546-170X
10.1038/nm.3652 doi
Apoptosis--drug effects
Apoptosis Regulatory Proteins--genetics
Carcinoma, Non-Small-Cell Lung--genetics
Drug Resistance, Neoplasm--drug effects
Female
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--genetics
Lung Neoplasms--genetics
Male
Membrane Proteins--genetics
Polymorphism, Genetic--genetics
Protein Kinase Inhibitors--pharmacology
Proto-Oncogene Proteins--genetics
Sequence Deletion--genetics